Transmission dynamics and economic impacts of sheeppox and goatpox disease outbreak in Chifra district of Afar Region Ethiopia.

Sheep and goatpox are caused by pox virus and economically very important. The study was conducted to estimate the economic losses due to sheep and goatpox, to estimate the morbidity and mortality as well as the transmission parameters. A cross sectional study was conducted in Chifra districts of Afar region from July 2020 to December 2020 using questioner survey. For the estimation of the economic impacts and the transmission parameters of the outbreak, a data was collected at the end of the outbreak through a direct face to face interview. Transmission parameters were estimated based on a final size approach. Whereas, economic impacts were estimated descriptively using different formulas based on the type of losses. The overall morbidity, mortality and case fatality of sheep and goatpox were 51.6%, 2.0%, and 3.9%, respectively. The average flock level losses due to treatment cost, mortality and abortion were 320.3, 1250 and 1195.6 Ethiopian birr (ETB), respectively. The outbreak caused a total of 63617 ETB losses in the district. The highest loss was due to mortality (28750ETB), whereas the least loss was due to treatment cost (7367ETB). The outbreak had 0.14 and 1.41 transmission rate parameters per day and basic reproduction ratio, respectively. There was a significant difference in the transmission of the infection between individual animals (p < 0.001). To limit the economic losses due to this disease, the farmers should give more attention towards this disease and a systematic control program comprising vaccination and limitation of movement of sheep and goat should be implemented to alleviate the losses due to sheep and goatpox.

Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication depends on the interaction between the viral proteins and the human translation machinery. The cytotoxic peptide plitidepsin was found to inhibit CoV-2 up to 90 % at a concentration of 0.88 nM. In vitro studies suggest that this activity may be attributed to the inhibition of the eukaryotic translation elongation factor 1A (eEF1A). However, recent reports raised the potential for other cellular targets which plitidepsin may use to exert its potent antiviral activity. The lack of data about these potential targets represents a major limitation for its structural optimization. This work describes the use of a molecular modeling approach to rationalize the in vitro antiviral activity of plitidepsin and to identify potential cellular targets. The developed protocol involves an initial molecular docking step followed by molecular dynamics and binding free energy calculations. The results reveal the potential for plitidepsin to bind to the active site of the key enzyme SARS-CoV-2 RdRp. The results also highlight the importance of van der Waals interactions for proper binding with the enzyme. We believe that the results presented in this study could provide the grounds for the optimization of plitidepsin analogs as SARS-CoV-2 inhibitors.